Delek US Holdings (DK) Tops Q2 EPS by 30c

Delek US Holdings (NYSE: DK) reported Q2 EPS of ($0.56), $0.30 better than the analyst estimate of ($0.86). Revenue for the quarter came in at $2.76 billion versus the consensus estimate of $2.67 billion.

DKL is executing well on its full year Adjusted EBITDA guidance of $480 to $520 million

For earnings history and earnings-related data on Delek US Holdings (DK) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c